Lincoln International Closed / Announced Six Transactions in Q4 2020 in the Pet and Animal Health Sectors
The pet and animal sectors continue to demonstrate resilience across the economic cycle; mergers and acquisitions (M&A) activity has proven investor appetite remains strong, even in the face of uncertainty as a result of the pandemic. Numerous attractive tailwinds, such as increased pet adoptions during lockdown and the humanization of pets, have kept investors watching the industry closely for opportunities.
Lincoln International closed six pet transactions in Q4 2020 across our Global Consumer and Healthcare Groups, including cross-border sales to both public and private equity clients. Acting as both buy-side and sell-side advisors for a variety of clients, from branded pet food to treats and consumables to veterinary services, notable deals include:
Pet:
Lincoln’s Global Healthcare Group continued their strong momentum in animal health. The Group has completed 50+ animal health transactions across all verticals, including hospitals, diagnostics, pharmaceuticals and technology.
As 2021 unfolds, Lincoln International expects M&A activity in this space to continue to be high. Connect with a senior member of the Lincoln International team to learn more.
Meet our Senior Team in Consumer
I take a long-term approach to building relationships and understanding clients' businesses in order to provide timely and relevant advice.
Alex Masters
Managing Director & Co-head of Consumer, Europe
London
Meet our Senior Team in Healthcare
It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.
Matthew Lee
Managing Director, Head of UK & Co-head of Healthcare, Europe
London
My goal is to bring the best of Lincoln to each and every transaction, ensuring the topmost outcomes for our clients.
Roderick O’Neill
Managing Director & Co-head of Healthcare
New York